½Ã°£ ÇÁ·Î±×·¥ ¿¬ÀÚ, ÁÂÀå
09:30~09:40 °³È¸»ç ÃÖº´¿Á(¼º±Õ°üÀÇ´ë, ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ ȸÀå)
¥°. New tools for managing neuromuscular disorder ÁÂÀå: ¹Ú±â´ö(ÀÌÈ­ÀÇ´ë), ¹Î¾ç±â(ÇѸ²ÀÇ´ë)
09:40~10:10 Neuroimaging biomarkers in neurodegenerative disease ¹é¼³Èñ(°í·ÁÀÇ´ë)
10:10~10:40 Patient-reported outcome measures and telemonitoring in ALS ¿ÀÁÖ¿¬(´Ü±¹´ëÇб³,°£È£´ëÇÐ)
10:40~10:50 Q & A
10:50~11:00 Intermission
¥±. New Classification! New diagnostic procedure! New treatment! in myopathy ÁÂÀå: ±Ç±âÇÑ(ÇѸ²ÀÇ´ë), ÃÖ¿µÃ¶(¿¬¼¼ÀÇ´ë)
11:00~11:20 Novel classification of myositis ÀÌÁ¾¸ñ(°æºÏÀÇ´ë)
11:20~11:40 Updated diagnostic approaches in myopathy
(Antibody testing? Biopsy first or NGS first? Do biopsy or not?)
±è½Â¿ì(¿¬¼¼ÀÇ´ë)
11:40~12:00 CAR-T Therapy in myositis ½ÅÁ¦¿µ(ÇѸ²ÀÇ´ë)
12:00~12:10 Q & A
12:10~13:10 Àӽà ÃÑȸ & Lunch
¥². Plenary Lecture ÁÂÀå: ÃÖº´¿Á(¼º±Õ°üÀÇ´ë)
13:10~13:50 Japan myasthenia gravis guideline and overview of relevant data for every biologics Hiroyuki Murai
(International University of Health and Welfare)
13:50~14:00 Q & A
14:00~14:10 Intermission
¥³. Scientific Session ÁÂÀå: ±è½ÂÇö(ÇѾçÀÇ´ë), ±èº´Á¶(°í·ÁÀÇ´ë)
14:10~14:25 1st (10ºÐ ¹ßÇ¥ - 5ºÐ Áú¹®)
14:25~14:40 2nd (10ºÐ ¹ßÇ¥ - 5ºÐ Áú¹®)
14:40~14:55 3rd (10ºÐ ¹ßÇ¥ - 5ºÐ Áú¹®)
14:55~15:10 4th (10ºÐ ¹ßÇ¥ - 5ºÐ Áú¹®)
¥´. Poster Session
15:10~15:40 Poster Session
¥µ. Research Highlight Track ÁÂÀå: ±è»ó¹ü(°æÈñÀÇ´ë), ÀÓ¿µ¹Î(¿ï»êÀÇ´ë)
15:40~15:55 1st (10ºÐ ¹ßÇ¥ - 5ºÐ Áú¹®)
15:55~16:10 2nd (10ºÐ ¹ßÇ¥ - 5ºÐ Áú¹®)
16:10~16:25 3rd (10ºÐ ¹ßÇ¥ - 5ºÐ Áú¹®)
16:25~ ÄûÁî Ãß÷ ¹× Æóȸ»ç



(03163) ¼­¿ï Á¾·Î±¸ Àλ絿±æ 12, 1111È£ (Àλ絿, ´ëÀϺôµù)
TEL : 02-720-1594 E-mail : knmd1594@daum.net
Copyright¨ÏKorean Society of Neuromuscular Disorders